News & Events
French study supports the idea of avoiding delays after pregnancy before starting natalizumab therapy
Fampridine must be used with caution in people with a history of MS-related trigeminal neuralgia
Researchers find that Alfacalcidol is a safe and effective treatment for fatigue
The register aims to address the recognised lack of relevant MS data at European level
The UK MS Society’s campaign calls for the right treatment at the right time
Volunteers from MS organisations in Lebanon, Egypt and Jordan took part in a three-day training course
This year’s McDonald Fellowships went to researchers from Bangladesh, Hungary, Iran and Yemen
The second wave of 2014 grants includes scientists from Iran, Italy, Romania and Russia
Pegylated interferon lasts longer, so needs to be taken less often, with fewer side effects
Alemtuzumab has been approved in Europe, Canada, Australia, and Latin America
The new test measures the risk of PML infection in people being treated with Natalizumab
An imbalance in the production of two molecules may play a role in MS inflammation